CJC-1295/Ipamorelin Blend is a synergistic peptide combination widely studied for its role in stimulating endogenous growth hormone (GH) release, supporting recovery pathways, and optimizing anabolic signaling. CJC-1295 (a long-acting GHRH analog) and Ipamorelin (a selective ghrelin receptor agonist) are individually recognized for promoting pulsatile GH secretion with minimal impact on cortisol and prolactin in research models. When combined, they offer complementary mechanisms that enhance both the amplitude and consistency of GH signaling, providing broad utility across studies involving tissue repair, metabolic function, body composition, and recovery.